Bendopnea and Its Clinical Importance in Outpatient Patients with Pulmonary Arterial Hypertension
- 1 November 2018
- journal article
- research article
- Vol. 34 (6) , 518-525
Abstract
Purpose: Bendopnea is a recently reported novel symptom in patients with heart failure (HF) defined as shortness of breath when bending forward. It has been demonstrated that bendopnea is associated with advanced symptoms and worse outcomes. The aim of this study was to assess the presence of bendopnea and its clinical importance with regards to functional status, hemodynamic and echocardiographic characteristics in outpatient pulmonary arterial hypertension (PAH) patients. Methods: We conducted this prospective observational study of 53 patients who were admitted to our PAH clinic for routine control visits. We determined the presence of bendopnea and analyzed hemodynamic parameters, World Heart Organization (WHO) functional class, transcutaneous oxygen saturation, 6-minute walking distance (6-MWD), N-terminal pro-brain natriuretic peptide (NT-proBNP) and right ventricular (RV) function indicators in patients with and without bendopnea. Results: Bendopnea was present 33.9% of the PAH patients. The mean age was higher in the patients with bendopnea than in those without bendopnea, but the difference was not significant (p = 0.201). The patients with bendopnea had a lower 6-MWD and higher NT-proBNP level (p < 0.001), and worse WHO functional class symptoms (p = 0.010). Mean right atrial pressure, pulmonary artery pressure, and pulmonary vascular resistance were higher in the patients with bendopnea. The patients with bendopnea had a more dilated RV end-diastolic diameter and lower tricuspid annular plane systolic excursion value (p < 0.001 and p = 0.001, respectively). Conclusions: Bendopnea was associated with worse functional capacity status, hemodynamic characteristics and RV function in our outpatient PAH patients.Keywords
This publication has 28 references indexed in Scilit:
- “Flexo-dyspnea”: A novel clinical observation in the heart failure syndromeThe Journal of Heart and Lung Transplantation, 2013
- Functional Class Improvement and 3-Year Survival Outcomes in Patients With Pulmonary Arterial Hypertension in the REVEAL RegistryChest, 2013
- Pulmonary arterial hypertension: Advances in pathophysiology and managementIndian Journal of Pharmacology, 2012
- Integration of Clinical and Hemodynamic Parameters in the Prediction of Long-term Survival in Patients With Pulmonary Arterial HypertensionChest, 2011
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management EraCirculation, 2010
- Predicting Survival in Pulmonary Arterial HypertensionCirculation, 2010
- Wide Variation in Clinicians' Assessment of New York Heart Association/World Health Organization Functional Class in Patients With Pulmonary Arterial HypertensionMayo Clinic Proceedings, 2009
- Value of Clinician Assessment of Hemodynamics in Advanced Heart FailureCirculation: Heart Failure, 2008
- Tricuspid Annular Displacement Predicts Survival in Pulmonary HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Long-term intravenous epoprostenol infusion in primary pulmonary hypertensionJACC, 2002